These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prazosin does not alter levels of plasma lipids, glucose, and insulin.
    Author: Cambien F, Plouin PF.
    Journal: J Cardiovasc Pharmacol; 1985; 7(3):516-9. PubMed ID: 2410683.
    Abstract:
    In a double-blind, randomized, cross-over study involving 15 mild hypertensive patients, the effects of prazosin (5.7 mg/day) and placebo on plasma levels of lipids, lipoproteins, glucose, and insulin were compared. After 5 weeks of treatment, prazosin had not significantly altered the mean levels of plasma cholesterol, phospholipids, and triglycerides in the high-density lipoprotein or low-density lipoprotein plus very low-density lipoprotein subfractions. Fasting and postload plasma levels of glucose and insulin were also unaffected.
    [Abstract] [Full Text] [Related] [New Search]